HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
PubMed
Right arrow PubMed Citation
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 57:M532-M538 (2002)
© 2002 The Gerontological Society of America

Prevalence of Dementia in Users of Hormone Replacement Therapy as Defined by Prescription Data

Diana B. Petittia, J. Galen Buckwaltera, Valerie C. Crooksa and Vicki Chiua

a Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena

Diana B. Petitti, Research and Evaluation, SCPMG, 393 East Walnut Street, Pasadena, CA 91188 E-mail: diana.b.petitti{at}kp.org.

Background. Studies of hormone replacement therapy (HRT) and dementia and cognitive impairment show mixed results. This study assessed the prevalence of dementia and cognitive impairment in users and nonusers of HRT defined using computer-stored prescription information.

Methods. The study involved 3924 women 75 years of age and older who were members of the Southern California Kaiser Permanente Medical Care Program in 1998. HRT use was determined based on prescription data for 1992–1998. Cognitive function and dementia were assessed using the Telephone Interview of Cognitive Status supplemented by the Telephone Dementia Questionnaire and medical record review.

Results. Odds ratios (ORs) for cognitive impairment/dementia showed expected associations with age, education, ethnicity, and a history of stroke or Parkinson's disease. After adjustment, the OR for cognitive impairment or dementia in HRT users compared with HRT nonusers was 0.91 (95% confidence interval 0.75–1.10). The adjusted ORs for all dementia and dementia without cause in HRT users compared with nonusers were 0.77 (95% confidence interval 0.59– 1.00) and 0.78 (0.58–1.05), respectively. Twenty percent of women with cognitive impairment or dementia who had been classified as HRT users by prescription (one prescription each year from 1992–1998) denied hormone use compared with 8.8% of women without impairment. Medical record review validated prescription information for the impaired women.

Conclusions. The study identified an important methodologic problem in studies of HRT and cognitive impairment and dementia that depend on recalled information about drug exposure. A protective effect of HRT for cognitive impairment and dementia was neither established nor ruled out based on the prescription data.




This article has been cited by other articles:


Home page
AJPHHome page
V. C. Crooks, J. Lubben, D. B. Petitti, D. Little, and V. Chiu
Social Network, Cognitive Function, and Dementia Incidence Among Elderly Women
Am J Public Health, July 1, 2008; 98(7): 1221 - 1227.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. B. Petitti, V. C. Crooks, V. Chiu, J. G. Buckwalter, and H. C. Chui
Incidence of Dementia in Long-term Hormone Users
Am. J. Epidemiol., March 15, 2008; 167(6): 692 - 700.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
V. C. Crooks, D. B. Petitti, S. B. Robins, and J. G. Buckwalter
Cognitive domains associated with performance on the Telephone Interview for Cognitive Status--modified
American Journal of Alzheimer's Disease and Other Dementias, January 1, 2006; 21(1): 45 - 53.
[Abstract] [PDF]


Home page
DementiaHome page
V. C. Crooks, J. G. Buckwalter, D. B. Petitti, K. K. Brody, and R. L. Yep
Self-reported severe memory problems as a screen for cognitive impairment and dementia
Dementia, November 1, 2005; 4(4): 539 - 551.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. B. Petitti, V. C. Crooks, J. G. Buckwalter, and V. Chiu
Blood Pressure Levels Before Dementia
Arch Neurol, January 1, 2005; 62(1): 112 - 116.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J. E. Morley and H. M. Perry III
Androgens and Women at the Menopause and Beyond
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2003; 58(5): M409 - 416.
[Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
W. A. Banks and J. E. Morley
Memories Are Made of This: Recent Advances in Understanding Cognitive Impairments and Dementia
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M314 - 321.
[Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
S. Asthana
Estrogen and Cognition: The Story So Far
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M322 - 323.
[Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
G. T. Grossberg and A. K. Desai
Management of Alzheimer's Disease
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M331 - 353.
[Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J. E. Morley
Editorial: Hot Topics in Geriatrics
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2003; 58(1): M30 - 36.
[Full Text] [PDF]




HOME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The Gerontological Society of America.